Myriad Genetics Inc. (MYGN): Today's Featured Diversified Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Myriad Genetics ( MYGN) pushed the Diversified Services industry higher today making it today's featured diversified services winner. The industry as a whole closed the day down 0.1%. By the end of trading, Myriad Genetics rose $1.01 (4.7%) to $22.39 on average volume. Throughout the day, 2,385,787 shares of Myriad Genetics exchanged hands as compared to its average daily volume of 2,451,300 shares. The stock ranged in a price between $21.32-$22.42 after having opened the day at $21.42 as compared to the previous trading day's close of $21.38. Other companies within the Diversified Services industry that increased today were: General Employment ( JOB), up 12.8%, Mistras Group ( MG), up 8.0%, CTPartners Executive Search ( CTP), up 6.3% and VirtualScopics ( VSCP), up 5.9%.

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. Myriad Genetics has a market cap of $1.6 billion and is part of the services sector. The company has a P/E ratio of 10.1, below the S&P 500 P/E ratio of 17.7. Shares are up 1.9% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Myriad Genetics a buy, 2 analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Myriad Genetics as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Swisher Hygiene ( SWSH), down 9.5%, Genetic Technologies ( GENE), down 8.2%, China HGS Real Estate ( HGSH), down 7.8% and Acorn Energy ( ACFN), down 7.2% , were all laggards within the diversified services industry with SBA Communications ( SBAC) being today's diversified services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the diversified services industry could consider iShares Dow Jones US Cons Services ( IYC) while those bearish on the diversified services industry could consider ProShares Ultra Short Consumer Sers ( SCC).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Emerson Electric, S&P Global, Ball Corp.: 'Mad Money' Lightning Round

Emerson Electric, S&P Global, Ball Corp.: 'Mad Money' Lightning Round

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

37 Stocks That Will Probably Keep Nosediving

37 Stocks That Will Probably Keep Nosediving

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Jazz Shares Lower Amid Notes Offering

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma